Abstract
Perfluorocarbon (PFC) emulsions are halogen-substituted carbon nonpolar oils with resultant enhanced dissolved respiratory gas (O2, N2, CO2, nitric oxide) capabilities. In the first demonstration of enhanced O2 solubility, inhaled PFC could sustain rat metabolism. Intravenous emulsions were then trialed as “blood substitutes.” In the last 10 yr, biocomputational modeling has enhanced our mechanistic understanding of PFCs. Contemporary research is now taking advantage of these physiological discoveries and applying PFCs as “oxygen therapeutics,” as well as ways to enhance other gas movements. One particularly promising area of research is the treatment of gas embolism (arterial and venous emboli/decompression sickness). An expansive understanding of PFC-enhanced diffusive gas movements through tissue and vasculature may have analogous applications for O2 or other respiratory gases and should provide a revolution in medicine. This review will stress the fundamental knowledge we now have regarding how respiratory gas movements are changed when intravenous PFC is present.
Publisher
American Physiological Society
Subject
Physiology (medical),Physiology
Reference80 articles.
1. Aleksandrin VV, Kozhura VL, Novoderzhkina IS, Moroz VV. [Effect of Perftoran on cerebral blood flow in the reperfusion period after global transient brain ischemia] (in Russian). Anestheziol Reanimatol 6: 50–52, 2003.
2. Key West abstracts
3. Dynamics of O2, CO2, lactate, and acid exchange during contractions and recovery
4. Reduction of cerebral infarction using the third circulation
5. A novel treatment for ischemic intracranial hypertension in cats.
Cited by
132 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献